Hugh O’Neill is the senior vice president and president of autoimmune and rare diseases at Mallinckrodt Pharmaceuticals. He manages all commercialization efforts and broad market access activities within the company’s specialty brands department, and has over 20 years of experience in new product planning and execution in the pharmaceutical industry. In 2015, he was the winner of the PM360 Elite award, which recognized his exceptional ability as a leader and innovator.
“A leader must be at the core a strong and grounded person,” says Hugh. “My positive outlook and overall resiliency are two of my strongest traits, and are also traits that define my Irish heritage.” His paternal and maternal bloodlines stem from Co. Monaghan and Co. Longford, respectively.
Hugh earned his bachelor’s degree in finance from Montclair State University and an M.B.A. in marketing from Seton Hall University. He has a wife, Lissa, and three children, Gregory, Lauren, and Samantha.